Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta Alethine in Myeloma
NCT00006466Phase 2Unknown
- Sponsor
- LifeTime Pharmaceuticals, Inc.
- Start
- Aug 2000
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of beta-alanine in multiple myeloma (MM), monoclonal gammopathy of undetermined significance (MGUS), sponsored by LifeTime Pharmaceuticals, Inc.. Status: unknown.
02
Drugs
beta-alanine
03
Conditions
multiple myeloma (MM)monoclonal gammopathy of undetermined significance (MGUS)
Beyond the preview
Go deeper on NCT00006466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006466.